Medicare Part D formulary coverage of disease-modifying therapies for multiple sclerosis

Authors

• Pengxiang Li, University of Pennsylvania
• Matthew J Klebanoff, University of Pennsylvania
• John K Lin, University of Texas M.D. Anderson Cancer Center
• Keya D Doshi, Lexington High School
• Salim Chahin, Washington University School of Medicine in St. Louis
• Jalpa A Doshi, University of Pennsylvania

Journal

JAMA Health Forum

Publication Date

4-3-2026

Volume

7

Issue

4

First Page

e260871

Document Type

Open Access Publication

DOI

10.1001/jamahealthforum.2026.0871

Rights and Permissions

Li P, Klebanoff MJ, Lin JK, Doshi KD, Chahin S, Doshi JA. Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis. JAMA Health Forum. 2026;7(4):e260871. doi:10.1001/jamahealthforum.2026.0871. This is an open access article distributed under the terms of the CC-BY-NC-ND License, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies. © 2026 Li P et al. JAMA Health Forum.

Recommended Citation

Li, Pengxiang; Klebanoff, Matthew J; Lin, John K; Doshi, Keya D; Chahin, Salim; and Doshi, Jalpa A, "Medicare Part D formulary coverage of disease-modifying therapies for multiple sclerosis." JAMA Health Forum. 7, 4. e260871 (2026).
https://digitalcommons.wustl.edu/oa_4/6530

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.